{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T10:44:57Z","timestamp":1743936297588},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Colorectal Disease"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aims\u2002<\/jats:bold> The biological relevance of bone marrow micrometastases (BMM) in colorectal cancer remains unknown. Here, we investigate their nature by examining the impact of the presence of BMM on metastatic disease\u2010free survival in a cohort of patients with this disease.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Sixty\u2010three consecutive patients undergoing surgery for colorectal cancer of any stage were studied after approval of the study protocol by the local ethics committee and with full individual informed consent<jats:bold>.<\/jats:bold> All had bilateral iliac crest bone marrow aspirates prior to operation. Aspirates were then examined for the presence of aberrant cytokeratin\u201018\u2010positive cells by a blinded observer using both flow cytometric and APAAP immunohistochemical techniques.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Mean follow\u2010up after surgery was 4.6 years (range 1.9\u20136.9) for those without hepatic metastases at diagnosis. Seven of 34 patients with Dukes\u2019 stage A or B developed metastatic disease after a mean interval of 4.7 years (range 3.8\u20136.8). However, only 2 of these patients demonstrated BMM at the time of surgery. Nine of 15 patients with Dukes\u2019 C carcinoma at the time of surgery subsequently developed metastases after a mean interval of 4.4 years (range 1.9\u20136.9). Again, only two of these patients had BMM detectable initially. In only three of the 14 patients known to have metastases at the time of operation (i.e. Dukes\u2019\u2018D\u2019 disease) were BMM found.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> The presence of BMM as detected by this methodology was not predictive of tumour recurrence or metastasis. This study does not support the consideration of adjuvant therapy based on the presence of BMM at a single pre\u2010operative time point in patients with colorectal cancer.<\/jats:p>","DOI":"10.1111\/j.1463-1318.2005.00792.x","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T09:16:54Z","timestamp":1117617414000},"page":"406-409","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The impact of bone marrow micrometastases on metastatic disease\u2010free survival in patients with colorectal carcinoma"],"prefix":"10.1111","volume":"7","author":[{"given":"O. J.","family":"O'Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. O.","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. P.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,6]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800810106"},{"key":"e_1_2_5_3_2","first-page":"737","article-title":"Colorectal cancer staging and adjuvant chemotherapy","volume":"4","author":"Geldmann A","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199803)67:3<194::AID-JSO11>3.0.CO;2-2"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92230-D"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401893"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01606.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90641-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07127-X"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2002.n.004"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.11.1967"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2002.04.005"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92987-Q"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.10223"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(86)90102-9"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03377.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.5.831"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1442"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(94)00522-T"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199805)68:1<34::AID-JSO8>3.0.CO;2-M"},{"key":"e_1_2_5_22_2","first-page":"2375","article-title":"Spectrum of cytokeratin\u2010positive cells in the bone marrows of colorectal carcinoma patients","volume":"24","author":"Shetye JD","year":"2004","journal-title":"Anticancer Res"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.02.152"},{"key":"e_1_2_5_24_2","volume-title":"Cancer Staging Manual","author":"American Joint Committee on Cancer","year":"1998"}],"container-title":["Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1318.2005.00792.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1463-1318.2005.00792.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:40:12Z","timestamp":1697427612000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1463-1318.2005.00792.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1463-1318.2005.00792.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1318.2005.00792.x","archive":["Portico"],"relation":{},"ISSN":["1462-8910","1463-1318"],"issn-type":[{"value":"1462-8910","type":"print"},{"value":"1463-1318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"2005-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}